HCA Healthcare Files 8-K on Operations, Officer Compensation
Ticker: HCA · Form: 8-K · Filed: Jan 30, 2024 · CIK: 860730
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, financial-condition, executive-compensation, operations
TL;DR
**HCA Healthcare just dropped an 8-K on operations and exec pay, keep an eye out for details.**
AI Summary
HCA Healthcare, Inc. filed an 8-K on January 30, 2024, reporting events that occurred on January 24, 2024. This filing indicates that the company is providing updates on its operations and financial condition, as well as potential changes in its executive compensation arrangements. For investors, this matters because it signals that important financial and leadership information is being disclosed, which could influence the stock's valuation and future performance.
Why It Matters
This filing signals that HCA Healthcare is updating the market on its financial health and executive compensation, which are key factors in assessing the company's stability and future direction.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of corporate events and does not inherently indicate a high level of risk, but rather a transparency in reporting.
Analyst Insight
A smart investor would review the full details of the 'Results of Operations and Financial Condition' and 'Compensatory Arrangements of Certain Officers' once they become available to understand the implications for HCA Healthcare's financial outlook and governance.
Key Players & Entities
- HCA Healthcare, Inc. (company) — the registrant filing the 8-K
- January 30, 2024 (date) — the filing date of the 8-K
- January 24, 2024 (date) — the date of the earliest event reported in the 8-K
- Delaware (company) — state of incorporation for HCA Healthcare, Inc.
- 001-11239 (company) — Commission File Number for HCA Healthcare, Inc.
FAQ
What is the purpose of HCA Healthcare, Inc.'s 8-K filing dated January 30, 2024?
The 8-K filing by HCA Healthcare, Inc. on January 30, 2024, serves to report on 'Results of Operations and Financial Condition' and 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', among other items, for events that occurred on January 24, 2024.
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 24, 2024, as stated in the 'Date of Report (Date of earliest event reported)' section.
What is the Commission File Number for HCA Healthcare, Inc. as listed in this filing?
The Commission File Number for HCA Healthcare, Inc. is 001-11239, as indicated in the filing.
Where is HCA Healthcare, Inc.'s principal executive office located according to the filing?
HCA Healthcare, Inc.'s principal executive office is located at One Park Plaza, Nashville, Tennessee 37203, as per the business address provided in the filing.
Under which items of Form 8-K did HCA Healthcare, Inc. provide information?
HCA Healthcare, Inc. provided information under 'Results of Operations and Financial Condition', 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits'.
Filing Stats: 1,144 words · 5 min read · ~4 pages · Grade level 9.7 · Accepted 2024-01-30 08:01:00
Key Financial Figures
- $900,000 — e Company has approved a base salary of $900,000 for Mr. Marks. In addition, in connecti
- $2,000,000 — with a total target grant date value of $2,000,000 (the "Equity Award"), with fifty percen
- $6 billion — onal share repurchase program for up to $6 billion of the Company's outstanding common sto
- $0.66 — d declared a quarterly cash dividend of $0.66 per share of the Company's common stock
Filing Documents
- d734797d8k.htm (8-K) — 31KB
- d734797dex991.htm (EX-99.1) — 237KB
- g734797dsp6a.jpg (GRAPHIC) — 29KB
- 0001193125-24-018748.txt ( ) — 450KB
- hca-20240124.xsd (EX-101.SCH) — 3KB
- hca-20240124_lab.xml (EX-101.LAB) — 17KB
- hca-20240124_pre.xml (EX-101.PRE) — 11KB
- d734797d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press Release, dated January 30, 2024. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. /s/ John M. Franck II John M. Franck II Vice President – Legal & Corporate Secretary Date: January 30, 2024